Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 78,893 | 90,891 | 78,626 | 93,468 | 90,714 |
| Cost of Goods | 46,327 | 56,315 | 53,530 | 58,809 | 46,554 |
| Gross Profit | 32,566 | 34,576 | 25,096 | 34,659 | 44,160 |
| Operating Expenses | 137,278 | 135,436 | 126,613 | 125,252 | 115,958 |
| Operating Income | -104,385 | -100,545 | -100,987 | -89,784 | -71,244 |
| Interest Expense | 267 | 2,611 | 2,423 | 2,921 | 3,234 |
| Other Income | 134,055 | 19,022 | 848 | 516 | 103 |
| Pre-tax Income | 29,403 | -84,134 | -102,562 | -92,189 | -74,375 |
| Net Income Continuous | 29,403 | -84,134 | -102,562 | -92,189 | -74,375 |
| Net Income | $29,403 | $-84,134 | $-102,562 | $-92,189 | $-74,375 |
| EPS Basic Total Ops | 0.18 | -0.55 | -0.76 | -0.87 | -0.83 |
| EPS Basic Continuous Ops | 0.18 | -0.55 | -0.76 | -0.87 | -0.83 |
| EPS Diluted Total Ops | 0.17 | -0.55 | -0.76 | -0.87 | -0.83 |
| EPS Diluted Continuous Ops | 0.17 | -0.55 | -0.76 | -0.87 | -0.83 |
| EPS Diluted Before Non-Recurring Items | -0.43 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-95,059 | $-90,298 | $-93,506 | $-80,171 | $-66,211 |